Emerging Insights into the Dysregulated Monocyte-Macrophage Axis in Necrotizing Enterocolitis

Authors: Gunasekaran, Vignesh; de Plaen, Isabelle G; Konnikova, Liza; Maheshwari, Akhil; Garg, Parvesh Mohan

Source journal: American journal of perinatology (2026-11-19)

DOI: 10.1055/a-3009-0071

Abstract

OBJECTIVE: To synthesize correlative human, descriptive transcriptomic, and murine evidence on the role of monocyte-macrophage dysregulation in the pathogenesis of necrotizing enterocolitis (NEC), using a structured evidence-tier framework not previously applied to this literature. STUDY DESIGN: Narrative synthesis and critical appraisal of the peer-reviewed literature on monocyte and macrophage biology in NEC, organized by evidentiary tier: correlative human biomarker and tissue data, descriptive single-cell transcriptomic profiling, and interventional murine studies (macrophage depletion and ferroptosis inhibition). RESULTS: The preterm intestinal macrophage shows paradoxically elevated TLR4 expression and an immature, fetal-derived phenotype lacking tolerogenic programming. Peripheral monocytopenia, particularly serial percentage decline in absolute monocyte count, correlates with NEC onset and severity across three independent cohorts and offers a zero-cost clinical biomarker. Single-cell transcriptomics identifies four functionally distinct macrophage subpopulations in NEC tissue, dominated by an oxidative-stress-related, injury-amplifying subtype. Murine studies provide supportive evidence for a mechanistic contribution: selective macrophage depletion attenuates transfusion-associated NEC-like injury, and pharmacologic inhibition of macrophage ferroptosis limits epithelial damage. Separately, epithelium-derived HMGB1 activates microglial TLR4, a resident macrophage-lineage population, linking intestinal injury to the neurodevelopmental impairment observed in survivors. CONCLUSION: Dysregulation of monocyte-macrophage pathways plays a significant role in the pathogenesis of NEC, supported by convergent correlative, descriptive, and interventional evidence. These findings reframe NEC as a disease of myeloid imbalance and identify macrophage-targeted strategies, including TLR4 modulation and ferroptosis-targeted therapy, as rational directions for future prevention and treatment.

Read the full text

Related topics

Related open access articles

Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.